Pinealon 4mg/ml 5ml vial

Pinealon 4 mg/mL (5 mL vial) is a synthetic tripeptide composed of glutamic acid, aspartic acid, and arginine (Glu-Asp-Arg). It belongs to a class of short peptides studied for their potential neuroprotective and regulatory effects on gene expression, particularly within the central nervous system. Pinealon has been investigated for its ability to modulate neuronal function, support cognitive processes, and protect against age-related neurodegeneration. Research suggests it may influence gene expression involved in neuronal survival, synaptic plasticity, and oxidative stress response. These effects are thought to occur through interaction with DNA regulatory regions and intracellular signaling pathways. At a concentration of 4 mg/mL in a 5 mL vial, the total content equals 20 mg of Pinealon, typically supplied as a sterile solution or for reconstitution in controlled research settings. Studies in experimental models have shown that Pinealon may improve cognitive performance, support memory function, and reduce neuronal damage under stress conditions. Research on Pinealon and short peptides demonstrates potential roles in neuroprotection and gene regulation: https://pubmed.ncbi.nlm.nih.gov/16080882/ Additional studies highlight its effects on neuronal aging and cognitive function: https://pubmed.ncbi.nlm.nih.gov/16806504/